Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It was PEMEX a few weeks back when some "news writers" stated as saying they had no agreement with CHMR... but as it turns out CHMR and PEMEX had some agreement. Makes you wonder what the Air Liquide news will turn out to be... Time will tell.
Cost of the technology according to the agreement is $5K/month fee plus 20% based on quarterly profits from future production. Its not that cheap!
In context, loosing 10K is not a good experience as stated in a previous post of yours... but it looks like that was not related to CHMR. Just checking...
krewlkat apart from your postings on this board since very recently, 9/11/12, have you emailed the CEO any questions about CHMR company which resulted in your "bad experience"?.
No promoter's ADs for CHMR was listed on this site...
http://www.randysads.com/?cityid=199&lang=en&search=chmr&view=ads&subcatid=386
I am curious as to why so much negative information on CHMR company starts to come up as soon as the share price starts to go up. Folks have been scared into selling.
Today's PR indicates that they have engaged a company to finalize refabrication of equipment to be used in the non-hydraulic extraction of oil-shale. The results from the project could
make it easier to apply it in he US too. That is a resonable plan to me.
http://www.equities.com/news/headline-story?dt=2012-09-13&val=475924&cat=energy
Thanks for the history, not that pleasant. My impression is that the 90 day project will retrofit equipment in order to apply pressure on the oil pockets using helium gas but I am not an expert in that field. The $5k purchase price of the technology could be an upfront cost and back loaded, depending on the agreement with the Chinese owner but I need to do more DD on that.
The 90 day deployment will be on existing wells 4,5,6 etc as explained in the PR. It is to replace the existing hydraulic units with the non-hydraulic unit by CHMR and hopefully it will produce better and safer oil extration results. No new well drilling will be required imo.
You're welcome. Volume is rather low.
I haven't seen anything refuting the science behind the non-hydraulic fracking method in general. It could work for CHMR and if it does the rest is history.
Heading $1+
You're welcome!
A letter to share holders from CEO filed on 8K.
Dear Fellow Shareholders,
The last few weeks have been simultaneously the most rewarding and the most challenging during my tenure as the Chairman and CEO of Chimera Energy Corp. The highs, and lows, are both noteworthy and deserve more discussion than can be achieved through a Press Release. I hope this letter will help bring you some clarity as to the current status of our company as well as our plans and goals for the future.
The past twelve months of our development efforts have culminated in a phenomenal opportunity for our Non-Hydraulic Fracturing technology to debut with PEMEX, one of the largest oil and gas producers in Latin America. Just getting an opportunity to work with such an established industry player is a major win for us. During our recent visit to PEMEX we discussed engineering plans to utilize our technology on 3 wells chosen by PEMEX. Once the final engineering plans are approved we will execute a definite agreement with PEMEX for the services to be provided. In the industry this is known as a Master Service Agreement. The Agreement will specify all of the operational and financial details of the services to be provided. Once this Agreement is reached will file the executed version with the SEC as part of a Current Report on Form 8-K.
Unfortunately, all is not roses. Over the past 3 weeks Chimera has become the target of what can only be described as a blatant misinformation campaign. These self-described “shorters” are running a highly coordinated campaign against our company consisting of falsehoods, slander and innuendo. This campaign has consisted of misleading and libelous articles posted on the trading website Seeking Alpha, attempts to extort information from our employees and attorneys, hundreds of repetitive postings clogging company message boards, not to mention the highly illegal practice of naked shorting.
For those of you who have read the “articles” and message board postings I thought it would be worthwhile to discuss a few of the blatant lies that have been told:
1. I am the majority stockholder of Chimera Energy Corp. I hold 67.54% of the issued and outstanding stock of the company. Per SEC rules and guidelines my stock holdings are included in the company’s filing with the SEC. I have never sold or transferred a single share of Chimera stock.
2. We have an executed Memorandum of Understanding with PEMEX related to our Non-Hydraulic Fracturing technology.
3. We have received a formal proposal request from PEMEX relating to the use of our technology on three wells identified and designated by PEMEX.
4. Simultaneous to the our work the engineering plans for the PEMEX wells we are negotiating the terms of the definitive Master Service Agreement that will spell out the terms and conditions of the services to be provided to PEMEX.
I had hoped that these “shorters” would make their money and find another company to denigrate, however it appears as though they have chosen to double down. This campaign became highly personal to me when a video posted by this group to the YouTube service attacked my family and included their contact information. This escalation leaves me no choice but to go on the offensive.
Over the next several days I will be working with our attorneys to devise a litigation strategy for getting to the bottom of this campaign. It will not be easy to find the perpetrators. They are well hidden behind anonymous email accounts and fake names. Our efforts may not lead to the ultimate perpetrators, but they will certainly expose the truth behind this attack campaign.
I ask each and every shareholder to carefully consider all of the information about the company when making your investment decisions. I believe that Chimera and our technology both have bright futures.
While I may not be able to speak directly to each and every shareholder, I ask that if you have any comments or concerns that you email us at ir@chimeraenergyusa.com .
Sincerely,
/s/ Charles Grob
Charles Grob
Chairman & CEO
http://investing.money.msn.com/investments/sec-filings/?symbol=CHMR
A Current Report on Form 8-K.
They may get additional funding from the DoD if their application is approved soon. The study itself may not take long since the target population is small which means less resources will be needed. They could pull it off with good management. Buyout option is also possible.
RGIN should be trading in the 3s by now, the product has big potential and is on FDA orhan drug status. IR will not comment on time-lines for filing the IND etc. but sure its getting closer everyday.
RGIN is also eligible for DoD grant funding as well its a matter of time to get the approval.
DD and correction: The Orphan Drug filing was a separate filing apart from the IND. The IND is yet to be filed, may be several months. NDA is the last leg after the IND for the marketing approval. Potential news like funding, buyout e.t.c. could break out who knows (imo)
Depends when the company finishes the study and submits the NDA application but the FDA expedited review could take 60 days after submission.
here is a Q&A link from their website:
http://www.regenicin.com/InvestorRelations/Presentations/index.htmlsion.
The IND (investigational new drug) application was already submitted to FDA which got them the Orphan Drug Status because the initial data submitted showed very promising results. Under the Orphan drug status they are authorized to conduct more expanded clinical studies on humans to support the marketing application, New Drug Application (NDA). FDA will waive some cost aspects of the NDA such as the user fee which could be over $1Million+ and tax credits.
Agree, RGIN is on fast track to FDA approval but the nay sayers really went after it. It needs to come up with a good follow-up program to counter. FDA fast track is a siginificant milestone for Pharma companies and most of them go on to do well.
RGIN is now worth more than before the orphan drug aprocval in view of the company being paid to do their own clinical studies by the FDA through the orphan drug program thus saving several millions in R&D cost. The pps should be going up not going down.
FDA will not designate an Orphan Drug status and waive the hefty prescription drug application user fee of $1M+ (in addition to other benefits to RGIN) if the product does no meet safety and efficacy standards to begin with. The article is twisted. RGIN is right on.
Any possibility of news soon?
Looks like tight control on this stock keeping it dowm.
Thanks linkerboy. I agree the stock needs exposure with the right news and the PPS will go through the roof. They have paid off their senior secured notes debt, very low O/S and solid programs to generate revenues - all possitive. Hope recovery comes back shortly.
I'm new. QTWW was trading above $1.00 just last Feb/March. Anyone knows the story? It has to maintain above $1.00 to continue listing in NASDAQ.
You are right surfguy, the 10Q should normaly record any revenues received. Tax filings as well. Good DD. The PRs over-promised, with no delivery or follow-ups. FEI is no longer liable for any standstill agreements - they all came and went. Puzzling situation waiting for news.
Nobody knows for sure at this point, the PRS are vague, meanwhile the company has left folks filling in the blanks. PPs is going down down the more folks buy. It may be all smokescreen at a paper $200k cost. IMO.
Well, ECOS deserves a deal very soon after many long years of toiling. Thier diesel/water emulsion fuel technology is cleaner (30% more efficient) compared to 16% of a similar technology I've seen on the market so far. The effiecncy rating alone will be a big advantage if they come to market. PPS should be trading .04-.06s by now. Thanks again for sharing.
Sorry for the typo: I meant sense of "humor"
Thanks benji2, you ave a good sense of hunor.
Benji2: How long do you think those hundreds of commitments (according to FEI and the CEO) are going to stick arround if they can get go somewhere else. So far FEI already skipped 2 standstill agreements and have issued a re-comittment letter to ECOS for the third time but with no time line. I think a product as good as M-FUEL (with huge revenue potential as advertised) should get the attention of financiers by now. What is the hold? One contract sale at a time is all they need to get some good track record.
Ecos has a strong market niche. The first contract executed will send pps sky rocketing.
Good listening to the CEO on the stockradio.com. Thanks for posting Benji2.
"Alkermes earned $0.3 million in royalty revenues from type II diabetes treatment Bydureon" - Positive sign for Amylon EU revenues so far. http://www.zacks.com/stock/news/69054/Revenues+Skyrocket+at+Merged+Alkermes
Some folks sold MHR to buy NGAS others sold NGAS to buy MHR. Its not clear where the advantage is at this point.
I think you're right; 0.55 is what to be voted on. It should have been higher. MHR stands to gain if pps goes higher than 0.55.